ADT-Resistant Metastatic Prostate Cancer

AUA2019 027IC AUA CRPC Guidelines And Therapeutic Advances In Metastatic Prostate CancerПодробнее

Understanding Metastatic Castration-Resistant Prostate CancerПодробнее

Urologic Oncology Investigators Discuss Clinical Research in Care of Patients with Prostate CancerПодробнее

04_04 Castrate Resistant Metastatic Prostate CancerПодробнее

The Importance of Diagnosing and Treating Oligometastatic Prostate Cancer and ADT UsageПодробнее

AUA Guidelines on Advanced Prostate Cancer Webcast (2023)Подробнее

Androgen Deprivation Therapy ADT in Prostate Cancer Treatment with Rana Mckay, MD EP 63Подробнее

Serum thymidine kinase 1 as a predicative biomarker in prostate cancerПодробнее

UROwebinar: Metastatic prostate cancerПодробнее

AUA Advanced Prostate Cancer Guidelines (2024)Подробнее

Castrate resistant prostate cancerПодробнее

Prostate Cancer Semester 221 Part 3Подробнее

UROwebinar: Paradigm shifts in metastatic hormone sensitive prostate cancer mHSPC Recent treatmentПодробнее

Treatment Updates for Advanced Prostate Cancer – 2023 ZERO Prostate Cancer SummitПодробнее

Burning Questions and Controversies in the Management of Advanced Prostate Cancer PatientsПодробнее

Treatment advances in metastatic prostate cancer - Dr. Edmond KwanПодробнее

Treatment sequencing for metastatic castration-resistant prostate cancerПодробнее

New Standards of Care for Advanced Prostate CancerПодробнее

Metastatic Castration Resistant Prostate Cancer (mCRPC) – Inroads in Improved OutcomesПодробнее